FR2068403B1 - - Google Patents

Info

Publication number
FR2068403B1
FR2068403B1 FR696934760A FR6934760A FR2068403B1 FR 2068403 B1 FR2068403 B1 FR 2068403B1 FR 696934760 A FR696934760 A FR 696934760A FR 6934760 A FR6934760 A FR 6934760A FR 2068403 B1 FR2068403 B1 FR 2068403B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR696934760A
Other versions
FR2068403A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CERPHA
Original Assignee
CERPHA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE757001D priority Critical patent/BE757001A/fr
Application filed by CERPHA filed Critical CERPHA
Priority to FR696934760A priority patent/FR2068403B1/fr
Priority to NL707014307A priority patent/NL146378B/xx
Priority to PL1970143598A priority patent/PL81077B1/pl
Priority to DE19702048372 priority patent/DE2048372C/de
Priority to ZA706708A priority patent/ZA706708B/xx
Priority to IL35400A priority patent/IL35400A/xx
Priority to CH1478270A priority patent/CH530976A/fr
Priority to US00078976A priority patent/US3758506A/en
Priority to SE7013630A priority patent/SE370698B/xx
Priority to JP45089272A priority patent/JPS4817272B1/ja
Priority to DK514670AA priority patent/DK125794B/da
Priority to ES384362A priority patent/ES384362A1/es
Priority to GB5817470*A priority patent/GB1323328A/en
Priority to HUPA1080A priority patent/HU162466B/hu
Priority to AT919270A priority patent/AT296972B/de
Publication of FR2068403A1 publication Critical patent/FR2068403A1/fr
Application granted granted Critical
Publication of FR2068403B1 publication Critical patent/FR2068403B1/fr
Priority to US05353986 priority patent/USB353986I5/en
Priority to US05/572,311 priority patent/US3969529A/en
Priority to HK626/78A priority patent/HK62678A/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
FR696934760A 1969-10-10 1969-10-10 Expired FR2068403B1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
BE757001D BE757001A (fr) 1969-10-10 Derives heterocycliques d'acides phenoxy acetique et leur preparation
FR696934760A FR2068403B1 (fr) 1969-10-10 1969-10-10
NL707014307A NL146378B (nl) 1969-10-10 1970-09-29 Werkwijze voor het bereiden van een geneesmiddel met diuretische werking.
PL1970143598A PL81077B1 (fr) 1969-10-10 1970-09-30
DE19702048372 DE2048372C (de) 1969-10-10 1970-10-01 2,3-Dichlorphenoxyessigsäuren
ZA706708A ZA706708B (en) 1969-10-10 1970-10-02 Phenoxyacetic acid derivatives
IL35400A IL35400A (en) 1969-10-10 1970-10-06 Furoyl and thenoylphenoxy acetic acid derivatives,their preparation and pharmaceutical compositions containing them
CH1478270A CH530976A (fr) 1969-10-10 1970-10-06 Procédé de préparation de nouveaux dérivés hétérocycliques d'acides phénoxy acétiques
US00078976A US3758506A (en) 1969-10-10 1970-10-07 Phenoxyacetic acid derivatives
SE7013630A SE370698B (fr) 1969-10-10 1970-10-08
JP45089272A JPS4817272B1 (fr) 1969-10-10 1970-10-09
DK514670AA DK125794B (da) 1969-10-10 1970-10-09 Analogifremgangsmåde til fremstilling af 2,3-dichlorphenoxyeddikesyrederivater.
ES384362A ES384362A1 (es) 1969-10-10 1970-10-09 Procedimiento para la obtencion de derivados del acido 2,3-dicloro fenoxi acetico.
GB5817470*A GB1323328A (en) 1969-10-10 1970-10-09 Phenoxyacetic acid derivatives
HUPA1080A HU162466B (fr) 1969-10-10 1970-10-10
AT919270A AT296972B (de) 1969-10-10 1970-10-12 Verfahren zur Herstellung von neuen heterocyclischen Verbindungen und ihren Salzen
US05353986 USB353986I5 (fr) 1969-10-10 1973-04-24
US05/572,311 US3969529A (en) 1969-10-10 1975-04-28 Phenoxyacetic acid derivatives as diuretic agents
HK626/78A HK62678A (en) 1969-10-10 1978-10-26 Phenoxyacetic acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR696934760A FR2068403B1 (fr) 1969-10-10 1969-10-10

Publications (2)

Publication Number Publication Date
FR2068403A1 FR2068403A1 (fr) 1971-08-27
FR2068403B1 true FR2068403B1 (fr) 1973-04-06

Family

ID=9041347

Family Applications (1)

Application Number Title Priority Date Filing Date
FR696934760A Expired FR2068403B1 (fr) 1969-10-10 1969-10-10

Country Status (16)

Country Link
US (1) US3758506A (fr)
JP (1) JPS4817272B1 (fr)
AT (1) AT296972B (fr)
BE (1) BE757001A (fr)
CH (1) CH530976A (fr)
DK (1) DK125794B (fr)
ES (1) ES384362A1 (fr)
FR (1) FR2068403B1 (fr)
GB (1) GB1323328A (fr)
HK (1) HK62678A (fr)
HU (1) HU162466B (fr)
IL (1) IL35400A (fr)
NL (1) NL146378B (fr)
PL (1) PL81077B1 (fr)
SE (1) SE370698B (fr)
ZA (1) ZA706708B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107172A (en) * 1974-03-01 1978-08-15 Abbott Laboratories Uricosuric diuretic composition
US3958004A (en) * 1974-04-23 1976-05-18 Merck & Co., Inc. Phenoxyacetic acid derivatives as uricosuric agents
US3969508A (en) * 1974-11-27 1976-07-13 Smithkline Corporation Lowering the concentration of plasma triglycerides
US3989838A (en) * 1975-09-22 1976-11-02 Smithkline Corporation Uricosuric compositions and method of producing uricosuria and hypouricemia
US4058559A (en) 1975-09-24 1977-11-15 Abbott Laboratories 4-Aroyl-substituted phenoxy acetic acids
US4255585A (en) * 1975-10-22 1981-03-10 Centre European De Recherches Pharmacologique Benzoheterocyclic derivatives of phenoxyacetic acid
US4017632A (en) * 1975-10-22 1977-04-12 Centre European De Recherches Pharmacologiques C.E.R.P.H.A. Phenoxyacetic acid derivatives
US4197309A (en) * 1976-10-12 1980-04-08 Albert Roland S.A. 4-Keto-phenoxyacetic acids
FR2386540A1 (fr) * 1977-04-06 1978-11-03 Rolland Sa A Derives d'acides furoyl- ou thenoyl- naphtyloxyalkylcarboxyliques, leur preparation et leur utilisation comme medicaments
GB1569404A (en) * 1977-04-22 1980-06-11 Soc D Etudes Prod Chimique (2-isopropyl-4-(2'-theonyl)-5-methyl) phenoxy acetic acid
US4115402A (en) * 1977-06-17 1978-09-19 Merck & Co., Inc. 2,3-Dichloro-4-[(substituted-sulfonyl)-phenoxy]-acetic acids
FR2399427A1 (fr) * 1977-08-04 1979-03-02 Rolland Sa A Nouveaux sels d'addition hydrosolubles de l'acide tienilique
US4107179A (en) * 1977-08-22 1978-08-15 Smithkline Corporation Method for preparing ticrynafen
US4089970A (en) * 1977-09-07 1978-05-16 Smithkline Corporation Method of inhibiting platelet aggregation
US4166061A (en) * 1977-11-02 1979-08-28 Smithkline Corporation Use of cyclic esters to prepare 2,3-dichloro-4-(2-thenoyl)phenoxyacetic acid
GR75464B (fr) * 1981-04-24 1984-07-20 Ciba Geigy
US4661607A (en) * 1984-09-21 1987-04-28 Chugai Seiyaku Kabushiki Kaisha Furoxanthone derivatives useful as diuretics
US4732906A (en) * 1985-04-08 1988-03-22 Chugai Seiyaki Kabushiki Kaisha Dioxolobenzizoxazole derivatives
JPS6219552A (ja) 1985-07-19 1987-01-28 Ono Pharmaceut Co Ltd ３−〔（４−アロイル）フエノキシ（またはフエニルチオ）〕シクロペンタンカルボン酸誘導体、それらの製造方法及びそれらを有効成分として含有する脳浮腫治療剤
US5458883A (en) * 1994-01-12 1995-10-17 Duke University Method of treating disorders of the eye
WO1995033456A2 (fr) * 1994-06-07 1995-12-14 Telor Ophthalmic Pharmaceuticals, Inc. Reduction de la pression intraoculaire au moyen d'acide aryloxyacetique et d'acide arylacetique
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
MXPA03004463A (es) 2000-11-21 2003-08-19 Sankyo Co Composiciones medicas.
BR0313593A (pt) 2002-08-19 2005-07-12 Pfizer Prod Inc Terapia de combinação para doenças hiperproliferativas
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
JP2008520578A (ja) * 2004-11-15 2008-06-19 ニトロメッド インコーポレーティッド 複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP2094643B1 (fr) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company Inhibiteurs d'amino cetp étendus
EP2986599A1 (fr) 2013-04-17 2016-02-24 Pfizer Inc. Dérivés de n-pipéridin-3-ylbenzamide dans le traitement des maladies cardiovasculaires
WO2015012205A1 (fr) 2013-07-23 2015-01-29 第一三共株式会社 Médicament destiné à la prévention ou au traitement de l'hypertension artérielle
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
CA3125765A1 (fr) 2019-01-18 2020-07-23 Astrazeneca Ab Inhibiteurs de pcsk9 et leurs procedes d'utilisation

Also Published As

Publication number Publication date
JPS4817272B1 (fr) 1973-05-28
US3758506A (en) 1973-09-11
GB1323328A (en) 1973-07-11
HK62678A (en) 1978-11-03
IL35400A0 (en) 1970-12-24
DK125794B (da) 1973-05-07
NL7014307A (fr) 1971-04-14
FR2068403A1 (fr) 1971-08-27
AT296972B (de) 1972-03-10
PL81077B1 (fr) 1975-08-30
BE757001A (fr) 1971-03-16
NL146378B (nl) 1975-07-15
HU162466B (fr) 1973-02-28
SE370698B (fr) 1974-10-28
DE2048372A1 (de) 1971-06-09
ES384362A1 (es) 1973-02-16
IL35400A (en) 1974-01-14
CH530976A (fr) 1972-11-30
ZA706708B (en) 1971-05-27

Similar Documents

Publication Publication Date Title
FR2068403B1 (fr)
AU465413B2 (fr)
AU450150B2 (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442380B2 (fr)
AU470661B1 (fr)
AU438128B2 (fr)
AU442285B2 (fr)
AU442322B2 (fr)
AU442357B2 (fr)
AU442535B2 (fr)
AU442463B2 (fr)
AU442538B2 (fr)
AU442554B2 (fr)
AT308690B (fr)
AU4540468A (fr)
CS149743B1 (fr)
AR203167Q (fr)
AU5109569A (fr)
AU5077469A (fr)
AU4949169A (fr)
BE737260A (fr)
BE735906A (fr)

Legal Events

Date Code Title Description
TP Transmission of property